| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.002 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.002 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.002 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.002 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |